Immunotherapy of cytotoxic T cell-resistant tumors by T helper 2 cells: an eotaxin and STAT6-dependent process.
about
Robust tumor immunity to melanoma mediated by interleukin-9-producing T cellsTumor-specific Th17-polarized cells eradicate large established melanomaIgE immunotherapy against cancerLymphocytes in cancer development: polarization towards pro-tumor immunityOpposing roles for CD34 in B16 melanoma tumor growth alter early stage vasculature and late stage immune cell infiltrationProcessing of tumor antigen differentially impacts the development of helper and effector CD4+ T-cell responsesThe duplicitous effects of interleukin 4 on tumour immunity: how can the same cytokine improve or impair control of tumour growth?Sipuleucel-T (Provenge) autologous vaccine approved for treatment of men with asymptomatic or minimally symptomatic castrate-resistant metastatic prostate cancer.AllergoOncology: the role of IgE-mediated allergy in cancer.Recent advances in eosinophil biology.Dendritic cell-based vaccines: barriers and opportunitiesRisk of cervical cancer associated with allergies and polymorphisms in genes in the chromosome 5 cytokine cluster.Synergy between CD8 T cells and Th1 or Th2 polarised CD4 T cells for adoptive immunotherapy of brain tumoursCancer immunotherapy: the past, the present and the future.Increased blood clotting, microvascular density, and inflammation in eotaxin-secreting tumors implanted into mice.IL-17-dependent, IFN-gamma-independent tumor rejection is mediated by cytotoxic T lymphocytes and occurs at extraocular sites, but is excluded from the eye.A case report - Volatile metabolomic signature of malignant melanoma using matching skin as a control.Eosinophils: 'new' roles for 'old' cells.Targeting dendritic cells with antigen-containing liposomes: antitumour immunity.Supernatural T cells: genetic modification of T cells for cancer therapy.Pivotal Advance: eosinophil infiltration of solid tumors is an early and persistent inflammatory host response.Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on primingBiological response modifiers as adjuncts to stem cell transplantation.Dendritic cell immunotherapy for breast cancer.Esophageal Squamous Cell Carcinoma Cells Modulate Chemokine Expression and Hyaluronan Synthesis in FibroblastsExpanding roles for CD4 T cells and their subpopulations in tumor immunity and therapy.Tumor eosinophil infiltration and improved survival of colorectal cancer patients: Iowa Women's Health StudyTh2-mediated anti-tumour immunity: friend or foe?Eosinophils in innate immunity: an evolving story.Depressed and anxious mood and T-cell cytokine expressing populations in ovarian cancer patients.Therapeutic strategies for harnessing human eosinophils in allergic inflammation, hypereosinophilic disorders, and cancer.Adoptive immunotherapy of cancer using CD4(+) T cells.Critical role of EBNA1-specific CD4+ T cells in the control of mouse Burkitt lymphoma in vivo.Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulation.Targeting CCL11 in the treatment of ovarian cancer.Enhancing adoptive immunotherapy of cancer.Interactions between the immune system and cancer: a brief review of non-spatial mathematical models.Myeloid cells in the tumor microenvironment: modulation of tumor angiogenesis and tumor inflammation.Tumor-associated macrophages as targets for tumor immunotherapy.T cell immunity in acute HIV-1 infection.
P2860
Q24601213-EC003F4F-C6D2-4F66-B4D7-630AF8ADFF50Q24648032-07BD4CDE-7C44-4B2D-B8F8-25E99927D77EQ28081223-62A0BDEE-DDA9-4E64-915E-3CB41DC69E56Q33712435-FFE0B433-E88E-47F6-91CF-A09E888A365EQ33873481-6FE5E3E3-5D75-4C12-A8C3-121E2F09CFAFQ33930126-55D91ADD-4E36-4BC6-ABD8-B82B085E490CQ34003186-966E6BDA-F24A-41CB-857B-2FB6E3992DD4Q34290252-6BE518B6-C9A6-4851-9E23-F0555C518427Q34394208-9C5BB19E-A79F-4BB5-AA1A-9D2E2E5B22A0Q34579906-4CD3EEAF-469E-4131-BC5C-AE1A25A26626Q34661797-1E1CCB6F-4B04-496B-A091-17F883B63065Q34676844-D8AEBB77-D3D6-436A-A0EB-8102B0109769Q34744875-D42B4EDF-44B7-416D-8EF7-9BDD5496DF9FQ35083647-0CC18DF2-7B27-4D48-9263-19A11D1E7055Q35102973-91466C2C-CC56-4AFF-B6CB-C3629F651A35Q35269684-3B0C2598-C142-449D-B383-E8A9B7A925D4Q35651462-48F01BC3-E794-4868-9084-CE0742DD73E7Q35674973-EBD20123-20DC-435F-9B4D-160BE8E400A1Q35925604-D0030AA5-B829-4CB9-BAF8-F3FC42271022Q36328805-8E3E10EB-085A-4958-80EF-4002921E6572Q36394033-F50E8E86-B879-47AD-865A-413676FFD83CQ36446446-B0D26778-8542-4618-BEE3-4A9989E8C917Q36446933-B4036B4A-3904-48F4-BAAB-77AADE226A4CQ36480998-EE6A3904-2D7F-489D-8423-A2D26E608455Q36594706-B2DC22DA-F9F1-473B-8A57-199E92537073Q36715205-76149B1A-927A-4697-922F-DCF2F9E13C0AQ36844909-0593D5F9-617A-4AFE-A51B-F978B9F6A3B9Q36845231-20E738D9-F2E7-4C30-B0AE-E8F81AEA62D5Q36921021-1CEC9673-428C-4C01-9608-096B5CCC0FE9Q37021430-8A4EA12D-7FD7-4646-B93B-A51B5AA44B4FQ37059851-16B892A5-60D8-4F94-83D3-DDD01F1E2C04Q37275304-F69C096C-581C-419F-8F89-0086BE808C66Q37286445-8B7474A4-EBF1-4305-AEB1-48EEAC7CD7C4Q37318263-D6713E06-19ED-4975-B2C5-C6A27CB8F59BQ37670242-D2FC676B-0115-44FB-ADBE-150491D6257FQ37687429-FF503A4D-569B-47BC-A84A-2526BFD3F449Q37708187-1D42EFD4-3F60-4FE1-A515-DEF97A880B0FQ37758250-706E730D-EBFA-40D1-B41B-980C904C386EQ37773280-AD9CA76F-5727-4794-B537-3C4FB9557270Q37789345-8ACC05A6-A1E1-4FB5-8DE9-920BDEF95C07
P2860
Immunotherapy of cytotoxic T cell-resistant tumors by T helper 2 cells: an eotaxin and STAT6-dependent process.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Immunotherapy of cytotoxic T c ...... n and STAT6-dependent process.
@ast
Immunotherapy of cytotoxic T c ...... n and STAT6-dependent process.
@en
type
label
Immunotherapy of cytotoxic T c ...... n and STAT6-dependent process.
@ast
Immunotherapy of cytotoxic T c ...... n and STAT6-dependent process.
@en
prefLabel
Immunotherapy of cytotoxic T c ...... n and STAT6-dependent process.
@ast
Immunotherapy of cytotoxic T c ...... n and STAT6-dependent process.
@en
P2093
P2860
P356
P1476
Immunotherapy of cytotoxic T c ...... in and STAT6-dependent process
@en
P2093
Christopher Parish
Joerg Mattes
Marc E Rothenberg
Paul Foster
Simon Hogan
P2860
P304
P356
10.1084/JEM.20021683
P407
P577
2003-02-01T00:00:00Z